Breakthrough Therapies: Market Dynamics and Investment Opportunities

Report Code: PHM176B

Publish Date: Dec 2024

Publisher: BCC Publishing

Category: Pharmaceuticals

Download Report OverviewTARIFF UPDATE

Limited Period Offer

CUSTOMIZE NOW

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for breakthrough therapy drugs was valued at $133.3 billion in 2023. This market is expected to grow from $150.6 billion in 2024 to $287.5 billion by 2029, at a compound annual growth rate (CAGR) of 13.8% from 2024 to 2029.

Report Includes

  • 26 data tables and 49 additional tables
  • An overview of the global market dynamics and investment opportunities for breakthrough therapy designation (BTD) drugs
  • Analyses of the global market trends, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
  • Evaluation and forecast the market size for breakthrough therapies based on type, and geographical region
  • Discussion of emerging technologies and developments and various macroeconomic factors affecting the breakthrough therapies market
  • Review of patent data and new developments regarding various categories and sub-categories of breakthrough therapies
  • A discussion on ESG challenges and practices of the industry
  • Assessment of the vendor landscape, including the market shares of leading companies, their product portfolios and financial overviews
  • Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments, product launches, and other strategic developments
  • Profiles of the leading market vendors, including F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bristol-Myers Squibb Co., Novartis AG and AstraZeneca

Report Scope

This report examines the potential risks and benefits of receiving breakthrough therapy designation (BTD), compares and contrasts fast-track drug development approaches (logistics, criteria and implications), and highlights the opportunities and challenges of creating breakthrough therapies. Cardiovascular, central nervous systems and neurology, rare diseases, oncology and other diseases are among the therapy areas in which this report analyzes BTD. It also examines leading companies, approved and pending products, and product revenues. It examines BTD’s achievements and shortcomings and discusses the tactics organizations use to optimize BTD’s competitive edge.

To provide an in-depth understanding of the market, this report also includes profiles of market participants, the competitive landscape, key competitors and respective market share.

The market in this report is divided into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2024-2029
Base year market size $133.3 Billion
Market size forecast $287.5 Billion
Growth rate CAGR of 13.8% from 2024 to 2029
Units considered $ Millions
Segments covered Therapy and Region
Regions covered North America, Europe, Asia-Pacific and Rest of the World (RoW)
Key Market Drivers
  • Increasing number of drugs gaining breakthrough status.
  • Expedited approval process in Europe.
  • Increasing prevalence of life-threatening conditions.
Companies studied
VERTEX PHARMACEUTICALS INC.ABBVIE INC.
ASTRAZENECA BRISTOL-MYERS SQUIBB CO.
F. HOFFMANN-LA ROCHE LTD.JOHNSON & JOHNSON SERVICES INC.
MERCK & CO. INC.NOVARTIS AG
PFIZER INC.REGENERON PHARMACEUTICALS INC.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The global breakthrough therapies market was valued at $133.3 billion in 2023 and is expected to reach $287.5 billion by the end of 2029. The market is expected to grow at a CAGR of 13.8% from 2024 to 2029.
Key factors that are driving the growth are:
  • Increasing number of drugs gaining breakthrough status.
  • Expedited approval process adopted in the Europe.
  • Increasing prevalence of life-threatening conditions.
The global breakthrough therapies market is segmented based on therapy, and region.
The oncology segment will dominate the market in 2029.
North America holds the highest share of the market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Breakthrough Therapies: Market Dynamics and Investment Opportunities114Free
Chapter- 1: Executive Summary4Free
Chapter- 2: Market Overview6Free
Chapter- 3: Market Dynamics7Free
Chapter- 4: Emerging Trends2Free
Chapter- 5: Regulatory Landscape4Free
Chapter- 6: Market Segmentation Analysis33Free
Chapter- 7: Competitive Intelligence11Free
Chapter- 8: Sustainability in the BDT Market: An ESG Perspective3Free
Chapter- 9: Appendix44Free
Published - Jan-2017| Analyst - Dr. Cheryl Lee Barton| Code - PHM176A

Report Highlights

The global market for breakthrough therapy designation drugs should reach $99.2 billion by 2022 from $48.8 billion in 2017 at a compound annual growth rate (CAGR) of 15.2%, from 2017 to 2022.

Report Includes

  • An overview of the global markets for breakthrough therapies, their dynamics, and investment opportunities
  • Analyses of global market trends, with data from 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2022
  • The challenges and opportunities of developing breakthrough therapies
  • A compare and contrast of different fast track drug development approaches (logistics, criteria and implications) and the potential risk and rewards of gaining break through designation
  • Analysis of the regulatory environment
  • Coverage of the market's dynamics, specifically growth drivers, restraints, and opportunities
  • Profiles of major players in the industry

Related Reports

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Neurology Market: A BCC Research Overview

Published - Feb 2025 | Publisher - BCC Publishing | Code - PHM215B

The global market for neurology is estimated to increase from $67.3 billion in 2024 to reach $94.8 billion by 2029, at a compound annual growth rate (CAGR) of 7.1% from 2024 through 2029.

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM062E

The global market for Alzheimer’s disease therapeutics and diagnostics was valued at $9 billion in 2023. This market is expected to grow from $9.7 billion in 2024 to $19.6 billion by 2029, at a compound annual growth rate (CAGR) of 15.1% from 2024 to 2029.

Drug Discovery Technologies

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO020H

The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.

Recent Reports

Over-the-Counter (OTC) Drugs, and Vitamins & Dietary Supplements: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - PHM050D

The global market for over-the- counter (OTC) drugs, vitamins and dietary supplements is expected to grow from $276.9 billion in 2025 and is projected to reach $371.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2025 to 2030.

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

Published - May 2025 | Publisher - BCC Publishing | Code - PHM263B

This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

The Global Influenza Market

Published - May 2025 | Publisher - BCC Publishing | Code - PHM049F

The global influenza market is expected to grow from $9.0 billion in 2024 and is projected to reach $12.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.2% during the forecast period of 2024 to 2029. 

Liver Disease Treatments: The Global Market

Published - Apr 2025 | Publisher - BCC Publishing | Code - PHM057D

The global market for liver disease treatments is estimated to increase from $46.0 billion in 2024 to reach $69.1 billion by 2030, at a compound annual growth rate (CAGR) of 7.1% from 2025 through 2030.

Cancer Immunotherapy: Technologies and Global Markets

Published - Apr 2025 | Publisher - BCC Publishing | Code - PHM129C

The global cancer immunotherapy market is expected to grow from $144.2 billion in 2024 and is projected to reach $247.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.4% during the forecast period of 2024 to 2029.

Top Trending Reports

Global Markets for Emerging Medical Device Technologies

Published - Mar 2025 | Publisher - BCC Publishing | Code - HLC191C

The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.

Global Diabetic Care Devices Market

Published - Feb 2025 | Publisher - BCC Publishing | Code - MDS019B

The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.

Generative AI: Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - IFT308A

The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.

2024 Medical Devices Research Review

Published - Mar 2025 | Publisher - BCC Publishing | Code - MDS060B

The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.

Single-Cell Genomics and Proteomics: Emerging Technologies and Markets

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO143C

The global market for single-cell genomics and proteomics is expected to grow from $4.0 billion in 2024 to reach $9.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Breakthrough Therapies: Market Dynamics and Investment Opportunities
Sample Report